AnalystsKaveri PohlmanKaveri Pohlman's Stock Forecasts
AnalystsKaveri Pohlman
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4746 out of 4929 analysts
Average Return
-17.3%
Win Rate
20%5 out of 25
Risk vs Reward
Poor
Good
Kaveri Pohlman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Checkmate Pharmaceuticals IncCMPI | +222.67% | $3.22 | $10.39 | 2022-03-29 - 2022-04-20 | Strong Buy |
Ambrx Biopharma IncAMAM | +137.69% | $11.78 | $28.00 | 2023-09-11 - 2024-03-06 | Strong Buy |
Macrogenics IncMGNX | +116.15% | $7.12 | $15.39 | 2023-03-20 - 2024-03-20 | Strong Buy |
Cytomx Therapeutics IncCTMX | +47.15% | $1.23 | $1.81 | 2022-07-06 - 2023-07-06 | Strong Buy |
Exelixis IncEXEL | +41.19% | $23.84 | $33.66 | 2023-12-18 - 2024-12-18 | Strong Buy |
Kaveri Pohlman Analyst Color
Get additional color on Kaveri Pohlman's coverage of popular stocks
Kaveri Pohlman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arrivent Biopharma IncAVBP | 1 | Strong Buy | $32.00 | +54.07% | Initiates Coverage On | 9 days ago |
Genmab AGMAB | 3 | Strong Buy | $47.00 | N/A | Maintains | a year ago |
Macrogenics IncMGNX | 3 | Strong Buy | $9.00 | N/A | Maintains | a year ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $30.00 | N/A | Maintains | a year ago |
Xencor IncXNCR | 1 | Strong Buy | $38.00 | N/A | Maintains | a year ago |
Nuvation Bio IncNUVB | 2 | Strong Buy | $5.00 | N/A | Upgrades | a year ago |
Janux Therapeutics IncJANX | 1 | Strong Buy | $62.00 | N/A | Initiates Coverage On | a year ago |
Pyxis Oncology IncPYXS | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Exelixis IncEXEL | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 2 years ago |
Ambrx Biopharma IncAMAM | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 2 years ago |
Arcus Biosciences IncRCUS | 1 | Strong Buy | $70.00 | N/A | Reiterates | 2 years ago |
Oncosec Medical IncONCSQ | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Shattuck Labs IncSTTK | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 3 years ago |
Cytomx Therapeutics IncCTMX | 2 | Strong Buy | $8.00 | N/A | Maintains | 3 years ago |
Neximmune IncNEXI | 1 | Strong Buy | $125.00 | N/A | Initiates Coverage On | 3 years ago |
Checkmate Pharmaceuticals IncCMPI | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Oncternal Therapeutics IncONCT | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 3 years ago |
Sonnet Biotherapeutics Holdings IncSONN | 2 | Strong Buy | $4,928.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.